Risk Of Death At One Year In Patients With Non-Small Cell Lung Cancer (Nsclc) Treated With Cisplatin Regimens- An Indirect Comparison Meta-Analysis Based On Renal Eligibility Criteria
May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.635
https://www.valueinhealthjournal.com/article/S1098-3015(13)00706-7/fulltext
Section Title :
Cancer
Section Order :
185
First Page :
A131
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)00706-7&doi=10.1016/j.jval.2013.03.635